CEL Online - 16th Annual University of Rochester Diabetes Conference – Diabetes Across the Ages
Date of Release
November 20, 2015
Period of Validity
November 20, 2015 – November 20, 2016
The prevalence and incidence of diabetes, is increasing worldwide. In the United States, over 25 million people (8.3% of the population) have diabetes, 7 million of which have not been diagnosed. There were 1.9 million new adult diagnoses in 2010 alone, and an alarming 79 million Americans are at risk of developing diabetes. Type 2 is the most common form, affecting 90-95% of adults diagnosed with diabetes. Diabetes is the seventh leading cause of mortality, and the risk of death amongst people with the disease is twice that of people without diabetes of a similar age. Diabetes is also the leading cause of kidney failure, lower limb amputations, and blindness in the United States, and is one of the leading causes of heart disease and stroke. Due to the complexity of the disease and its comorbidities, management of diabetes can be complicated. The advent of new drugs and treatment options adds another layer of complexity, making it difficult for primary care providers to make decisions surrounding optimal treatment plans. According to the Centers for Disease Control, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen. (4) (Saydah SH, Fradkin J and Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-42). The financial burden of diabetes is huge: total treatment costs in the United States add up to approximately $174 million per year.
Unfortunately, Monroe County is behind the curve with regards to the diagnosis and treatment of diabetes. According to the CDC, 8.5% of adults in Monroe County have been diagnosed with Diabetes and 30% of adults in Monroe County are considered to be obese. (Centers for Disease Control and Prevention: National Diabetes Surveillance System. Available online at: http://apps.nccd.cdc.gov/DDTSTRS/default.aspx. Retrieved 6/8/2012The shortage of endocrinologists in Rochester and surrounding areas (there are approximately 12 full-time endocrinologists, or one endocrinologist for every 6900 individuals with diabetes), means that primary care providers in this region carry the burden of trying to prevent, diagnose and treat diabetes and its associated complications.
This educational activity will provide primary care physicians, pediatricians, mid-level providers, endocrinologists, nephrologists, dieticians, and other allied health professionals with updates in diabetes research and treatment options, including discussion of diabetes treatment for patients of all ages, from children to pregnant women to the elderly. Discussion will also include updates on new treatment options, including advances in technology as well as the emergence of a new class of diabetes drugs called SGLT2 inhibitors.
At the conclusion of this activity, participants should be able to:
Explain the difficulties facing diabetic children and their families and develop strategies to help overcome these difficulties.
Identify the problems that children/teens have when switching from pediatricians to physicians treating adults and develop strategies to overcome these problems.
Explain the problems associated with diabetes and pregnancy and know how to advise these patients.
Describe the unique problems that face elderly patients with diabetes and develop strategies to allow the safest and best diabetes care in this population.
Summarize the risks and benefits of SGLT2 treatment in type 2 diabetes.
Identify the new technologies and new insulins that now exist for treating patients with diabetes.
Bibliographic Sources to Allow for Further Study
http://apps.nccd.cdc.gov/DDTSTRS/default.aspx. Retrieved 6/8/2012
ACOG Practice Bulletin # 137; 2013
Laudon etal: A Multicenter Randomized Trial of Treatment for Mild GDM. NEJM 2009
Wilding JP. The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors. Metabolism 2014; 63:1228-1237
Bakris GL, Fonseca VA, Sharma K, Wright EM. Renal Sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Kidney Int 2009; 75:1272-1277.
The University of Rochester School of Medicine & Dentistry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The University of Rochester School of Medicine and Dentistry designates this enduring material for a maximum of 6.75 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Planning Committee and Author/Speaker Declarations
The ACCME Standards of Commercial Support require that presentations be free of commercial bias and that any information regarding commercial products/services be based on scientific methods generally accepted by the medical community. All of the planning committee members (listed here) have declared that they have no financial interests or relationships to disclose:
The following authors/speakers have disclosed financial interests/arrangements or affiliations with organizations that could be perceived as real or apparent conflict of interest in the context of the subject of their presentation(s). Only the current arrangements/interests are included:
We Gratefully Acknowledge Educational Grants from the Following Companies:
No commercial funds have been received to support this educational activity
For questions regarding certification or credit reports:
University of Rochester Medical Center
Center for Experiential Learning
Phone: (585) 275-7666
Criteria for Successful Completion of this Activity Include:
Review the webcast
Completion of the self-assessment / program evaluation*
*The self-assessment / program evaluation must be completed in one sitting.
Will be available for download immediately following completion of the program evaluation.
Participants must download and save or print certificates before exiting the course.
Please remember to send a copy of your certificate to your credentialing office and to keep a copy for your records.